Barclays Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)
Barclays analyst Peter Lawson maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00.
AUKUS agreement to get ‘strong support’ in Trump administration, Marco Rubio says
Incoming Secretary of State for Donald Trump’s second term in the White House, Marco Rubio, says that the AUKUS agreement is ...
XRP Price Surges Past $3. These 3 Factors are Turbocharging the Crypto.
Bitcoin saw a sharp decline in price during much of the past week. Bitcoin's slide was mirrored by altcoins across crypto with Ethereum, Solana, and Dogecoin all losing as much or more than the oldest ...
Bitcoin Price Rises After CPI Inflation Report. Why the Data Matter for Crypto.
Whales have amassed almost 1 billion Dogecoin (CRYPTO: DOGE) within a span of 48 hours. What Happened: Cryptocurrency trader ...
Journal Gazette and Times Courier23h
Millions have had student loans canceled under Biden — despite the collapse of his forgiveness plan
Despite failing to deliver broad student loan forgiveness, Biden has now overseen the cancellation of student loans for more ...